DCGI
COVID-19 Vaccine Update: Serum Institute of India Seeks Emergency Use Authorisation for Oxford COVID-19 Vaccine Covishield in India
COVID-19 Vaccine: ‘Government Never Spoke Of Vaccinating Entire Country’ Says Rajesh Bhushan, Health Secretary
COVID-19 Vaccine Update: Initial Findings Into Adverse Event Did Not Necessitate Halting of Oxford Vaccine Trial, Says Health Ministry
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
Oxford Vaccine: Chennai Man Who Volunteered For Trials Seeks Rs 5 Crore Compensation, Says Suffered 'Neurological and Psychological Issues'
Sputnik V, Russia's COVID-19 Vaccine Arrives In India For Phase 2/3 Trials, Watch Video; Govt Pins Hope On Five Coronavirus Vaccines Under Trial In India
Sputnik V Vaccine Update: First Batch of Russian COVID-19 Vaccine to Arrive in Kanpur Medical College for Phase 2, 3 Trials
COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddy’s Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials
COVID-19 Vaccine Update: Dr Reddy’s, RDIF Get DCGI Nod for Clinical Trial of Sputnik V in India
COVID-19 Vaccine: Bharat Biotech Asked to Submit Complete Phase 2 Data of Its Vaccine Before Phase 3 Clinical Trial
COVID-19 Vaccine Update: Dr Reddy’s Asked to Reapply for Phase 2, 3 Clinical Trials of Russian Vaccine ‘Sputnik V’
COVID-19 Vaccine Update: Covaxin to Use ViroVax’s Adjuvant Alhydroxiquim-II to Boost Immune Response
Sputnik V Vaccine Update: Dr Reddy's Seeks DCGI Nod for Conducting Phase-3 Clinical Trial of Russian COVID-19 Vaccine
Feluda Test For COVID-19: Tata Group Launches Rs 500 Detection Kit For Coronavirus; Know Everything About The Development
COVID-19 Low-Cost Test 'Feluda', Launched by Tata Group And CSIR-IGIB, Gets DCGI's Approval
COVID-19 Vaccine Update: DCGI Gives Nod to Serum Institute to Restart Phase 2, 3 Trials for AstraZeneca Vaccine
Google Trends